- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Celldex Therapeutics Inc
Add to PortfolioCLDX:US
4.5000 USD 0.0200 0.45%As of 20:10:00 ET on 05/25/2012.
Snapshot for Celldex Therapeutics Inc (CLDX)
| Open: | 4.4400 | Day's Range: | 4.2300 - 4.5300 | Volume: | 1,963,229 | Bid: | 4.5100 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 4.4800 | 52wk Range: | 2.0500 - 5.6600 | 1-Yr Rtn: | +19.68% | Ask: | 4.5200 |
Key Statistics for CLDX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -1.1000 |
| Est. EPS (USD) (12/2012) | -1.0120 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 264.31 |
| Shares Outstanding (M) | 58.74 |
| Enterprise Value (M USD) (ttm) | 187.37 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 2.4499 |
| Price/Sale (ttm) | 21.5065 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/03/2012 |
More CLDX Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for CLDX
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for CLDX
Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.
| Larry EllbergerChairman | Anthony Salvatore MarucciPresident/CEO |
| Ronald A PepinSr VP/Chief Business Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page